Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
28.80
+1.24 (4.50%)
Oct 14, 2025, 4:00 PM EDT - Market closed
Anbio Biotechnology Employees
Anbio Biotechnology had 27 employees as of December 31, 2024.
Employees
27
Change
n/a
Growth
n/a
Revenue / Employee
$303,154
Profits / Employee
$87,883
Market Cap
1.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NNNN News
- 4 days ago - Anbio Biotechnology's Hype And Hard Approvals Suggest A Stretched Valuation - Seeking Alpha
- 2 months ago - Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewsWire
- 5 months ago - Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions - GlobeNewsWire
- 8 months ago - U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha
- 8 months ago - Anbio Biotechnology Announces Closing of Initial Public Offering - GlobeNewsWire
- 8 months ago - Anbio Biotechnology Announces Pricing of Initial Public Offering - GlobeNewsWire
- 10 months ago - U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings - Seeking Alpha
- 10 months ago - Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha